| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.582 | 0.008 | 0.582 | Anticonvulsant | 0.251 0.057 CID_54520268 | ||
| 0.544 | 0.008 | 0.544 | Psychostimulant | 0.461 0.015 CID_54520268 | ||
| 0.509 | 0.032 | 0.509 | Aldehyde oxidase inhibitor | 0.376 0.051 CID_54520268 | ||
| 0.478 | 0.044 | 0.478 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.448 0.063 CID_54520268 | ||
| 0.446 | 0.012 | 0.446 | Anesthetic general | 0.345 0.025 CID_54520268 | ||
| 0.394 | 0.001 | 0.394 | p53 inhibitor | |||
| 0.409 | 0.025 | 0.46 | Interleukin 2 agonist | 0.46 0.014 CID_54520268 | CID_54520268 | |
| 0.428 | 0.05 | 0.428 | GABA C receptor rho-3 antagonist | 0.341 0.091 CID_54520268 | ||
| 0.376 | 0.011 | 0.376 | Lipocortins synthesis antagonist | 0.335 0.015 CID_54520268 | ||
| 0.424 | 0.066 | 0.6 | Calcium channel L-type activator | 0.6 0.005 CID_54520268 | CID_54520268 | |
| 0.367 | 0.03 | 0.367 | Sodium/bile acid cotransporter inhibitor | 0.293 0.086 CID_54520268 | ||
| 0.43 | 0.094 | 0.494 | Caspase 9 stimulant | 0.494 0.062 CID_54520268 | CID_54520268 | |
| 0.402 | 0.077 | 0.496 | 5 Hydroxytryptamine release inhibitor | 0.496 0.034 CID_54520268 | CID_54520268 | |
| 0.326 | 0.003 | 0.326 | GABA aminotransferase inhibitor | 0.137 0.01 CID_54520268 | ||
| 0.343 | 0.031 | 0.427 | Interleukin agonist | 0.427 0.015 CID_54520268 | CID_54520268 | |
| 0.348 | 0.037 | 0.348 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.267 0.091 CID_54520268 | ||
| 0.345 | 0.04 | 0.345 | Cardiotonic | 0.32 0.048 CID_54520268 | ||
| 0.31 | 0.007 | 0.47 | Ferrochelatase inhibitor | 0.47 0.003 CID_54520268 | CID_54520268 | |
| 0.354 | 0.056 | 0.354 | 5 Hydroxytryptamine release stimulant | 0.272 0.079 CID_54520268 | ||
| 0.315 | 0.019 | 0.315 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.284 0.034 CID_54520268 | ||
| 0.322 | 0.046 | 0.322 | Tumour necrosis factor alpha release inhibitor | 0.304 0.052 CID_54520268 | ||
| 0.309 | 0.038 | 0.413 | Cyclic AMP phosphodiesterase inhibitor | 0.413 0.015 CID_54520268 | CID_54520268 | |
| 0.322 | 0.071 | 0.406 | Calcium channel activator | 0.406 0.023 CID_54520268 | CID_54520268 | |
| 0.295 | 0.045 | 0.317 | DNA synthesis inhibitor | 0.317 0.038 CID_54520268 | CID_54520268 | |
| 0.315 | 0.074 | 0.37 | Immunomodulator | 0.37 0.053 CID_54520268 | CID_54520268 | |
| 0.254 | 0.022 | 0.361 | Alpha-N-acetylglucosaminidase inhibitor | 0.361 0.011 CID_54520268 | CID_54520268 | |
| 0.313 | 0.083 | 0.313 | Cholesterol antagonist | 0.302 0.09 CID_54520268 | ||
| 0.31 | 0.092 | 0.342 | Vasodilator, peripheral | 0.342 0.077 CID_54520268 | CID_54520268 | |
| 0.226 | 0.008 | 0.226 | Glutamate (mGluR) agonist | 0.13 0.017 CID_54520268 | ||
| 0.263 | 0.056 | 0.263 | Tyrosine 3 hydroxylase inhibitor | 0.241 0.077 CID_54520268 | ||
| 0.268 | 0.065 | 0.268 | 5 Hydroxytryptamine uptake stimulant | 0.238 0.093 CID_54520268 | ||
| 0.244 | 0.053 | 0.244 | RNA-directed DNA polymerase inhibitor | 0.224 0.069 CID_54520268 | ||
| 0.213 | 0.023 | 0.213 | GABA C receptor rho-2 antagonist | 0.151 0.072 CID_54520268 | ||
| 0.207 | 0.019 | 0.209 | GABA C receptor agonist | 0.209 0.019 CID_54520268 | CID_54520268 | |
| 0.229 | 0.049 | 0.25 | Nitric-oxide synthase stimulant | 0.25 0.032 CID_54520268 | CID_54520268 | |
| 0.292 | 0.128 | 0.407 | Histamine release inhibitor | 0.407 0.072 CID_54520268 | CID_54520268 | |
| 0.179 | 0.018 | 0.179 | GABA C receptor antagonist | 0.149 0.03 CID_54520268 | ||
| 0.177 | 0.028 | 0.215 | Adenylate cyclase stimulant | 0.215 0.008 CID_54520268 | CID_54520268 | |
| 0.236 | 0.096 | 0.236 | Gastrin inhibitor | 0.208 0.138 CID_54520268 | ||
| 0.163 | 0.025 | 0.205 | UDP-glucose 4-epimerase inhibitor | 0.205 0.017 CID_54520268 | CID_54520268 | |
| 0.158 | 0.022 | 0.158 | DNA directed RNA polymerase inhibitor | 0.09 0.07 CID_54520268 | ||
| 0.155 | 0.019 | 0.155 | GABA C receptor rho-1 antagonist | 0.121 0.039 CID_54520268 | ||
| 0.183 | 0.051 | 0.183 | Arachidonic acid antagonist | 0.183 0.05 CID_54520268 | ||
| 0.188 | 0.059 | 0.214 | Succinate dehydrogenase inhibitor | 0.214 0.039 CID_54520268 | CID_54520268 | |
| 0.157 | 0.032 | 0.157 | GABA receptor agonist | |||
| 0.25 | 0.127 | 0.253 | Transcription factor NF kappa B inhibitor | 0.253 0.125 CID_54520268 | CID_54520268 | |
| 0.138 | 0.016 | 0.138 | Cyclin B3 inhibitor | 0.063 0.052 CID_54520268 | ||
| 0.131 | 0.013 | 0.131 | Glycine receptor antagonist | 0.116 0.02 CID_54520268 | ||
| 0.212 | 0.095 | 0.227 | Vasodilator | 0.227 0.084 CID_54520268 | CID_54520268 | |
| 0.14 | 0.024 | 0.158 | Anabolic | 0.158 0.014 CID_54520268 | CID_54520268 | |
| 0.149 | 0.038 | 0.177 | Microtubule formation inhibitor | 0.177 0.026 CID_54520268 | CID_54520268 | |
| 0.207 | 0.096 | 0.269 | Platelet antagonist | 0.269 0.064 CID_54520268 | CID_54520268 | |
| 0.193 | 0.084 | 0.193 | Neurotrophic factor enhancer | 0.193 0.083 CID_54520268 | ||
| 0.12 | 0.012 | 0.142 | Protein kinase C eta inhibitor | 0.142 0.008 CID_54520268 | CID_54520268 | |
| 0.175 | 0.069 | 0.175 | Antipruritic | 0.148 0.097 CID_54520268 | ||
| 0.216 | 0.111 | 0.282 | Immunostimulant | 0.282 0.084 CID_54520268 | CID_54520268 | |
| 0.136 | 0.031 | 0.152 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.152 0.026 CID_54520268 | CID_54520268 | |
| 0.213 | 0.109 | 0.314 | Spasmolytic | 0.314 0.065 CID_54520268 | CID_54520268 | |
| 0.188 | 0.085 | 0.188 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.14 | 0.038 | 0.14 | Photosensitizer | 0.139 0.038 CID_54520268 | ||
| 0.148 | 0.048 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.163 0.02 CID_54520268 | CID_54520268 | |
| 0.162 | 0.064 | 0.201 | Interferon gamma antagonist | 0.201 0.04 CID_54520268 | CID_54520268 | |
| 0.111 | 0.018 | 0.111 | Protein kinase C alpha inhibitor | 0.104 0.02 CID_54520268 | ||
| 0.263 | 0.174 | 0.263 | MAP kinase kinase 6 inhibitor | |||
| 0.101 | 0.022 | 0.101 | Phosphodiesterase III inhibitor | |||
| 0.198 | 0.119 | 0.198 | Superoxide dismutase inhibitor | 0.167 0.16 CID_54520268 | ||
| 0.154 | 0.074 | 0.154 | Diuretic | 0.142 0.084 CID_54520268 | ||
| 0.089 | 0.012 | 0.089 | MDM2 inhibitor | 0.069 0.041 CID_54520268 | ||
| 0.117 | 0.039 | 0.117 | Electrolyte absorption antagonist | 0.105 0.051 CID_54520268 | ||
| 0.147 | 0.072 | 0.147 | Hemostatic | 0.14 0.081 CID_54520268 | ||
| 0.081 | 0.009 | 0.081 | Guanylate cyclase stimulant | 0.068 0.011 CID_54520268 | ||
| 0.099 | 0.028 | 0.099 | Lipase inhibitor | 0.085 0.038 CID_54520268 | ||
| 0.211 | 0.141 | 0.211 | Insulysin inhibitor | |||
| 0.104 | 0.035 | 0.44 | Phosphodiesterase 4D inhibitor | 0.44 0.004 CID_54520268 | CID_54520268 | |
| 0.107 | 0.042 | 0.112 | Androgen antagonist | 0.112 0.038 CID_54520268 | CID_54520268 | |
| 0.075 | 0.01 | 0.075 | Adenylate cyclase 1 inhibitor | 0.048 0.029 CID_54520268 | ||
| 0.084 | 0.021 | 0.084 | Calcium channel T-type blocker | |||
| 0.068 | 0.008 | 0.092 | Membrane dipeptidase inhibitor | 0.092 0.004 CID_54520268 | CID_54520268 | |
| 0.072 | 0.012 | 0.074 | Pregnane X receptor antagonist | 0.074 0.01 CID_54520268 | CID_54520268 | |
| 0.128 | 0.07 | 0.128 | Vanilloid 1 agonist | |||
| 0.081 | 0.025 | 0.097 | Biliverdin reductase inhibitor | 0.097 0.019 CID_54520268 | CID_54520268 | |
| 0.1 | 0.045 | 0.105 | Ornithine decarboxylase inhibitor | 0.105 0.039 CID_54520268 | CID_54520268 | |
| 0.114 | 0.059 | 0.114 | Acetylcholine release stimulant | |||
| 0.075 | 0.022 | 0.075 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.109 | 0.055 | 0.17 | Adenylate kinase inhibitor | 0.17 0.02 CID_54520268 | CID_54520268 | |
| 0.078 | 0.025 | 0.078 | Androgen agonist | 0.076 0.026 CID_54520268 | ||
| 0.143 | 0.089 | 0.143 | CF transmembrane conductance regulator agonist | |||
| 0.102 | 0.051 | 0.102 | Protein kinase C delta inhibitor | 0.088 0.065 CID_54520268 | ||
| 0.091 | 0.04 | 0.091 | Porphobilinogen synthase inhibitor | 0.089 0.041 CID_54520268 | ||
| 0.143 | 0.092 | 0.191 | Melanin inhibitor | 0.191 0.045 CID_54520268 | CID_54520268 | |
| 0.1 | 0.053 | 0.1 | Interleukin 12 antagonist | 0.091 0.07 CID_54520268 | ||
| 0.061 | 0.014 | 0.061 | AICAR transformylase inhibitor | |||
| 0.052 | 0.005 | 0.052 | Protein kinase C beta II inhibitor | 0.045 0.008 CID_54520268 | ||
| 0.149 | 0.104 | 0.149 | Neurotensin receptor agonist | |||
| 0.066 | 0.021 | 0.073 | Dihydroorotate oxidase inhibitor | 0.073 0.014 CID_54520268 | CID_54520268 | |
| 0.09 | 0.046 | 0.09 | Acetylcholine nicotinic antagonist | |||
| 0.046 | 0.004 | 0.051 | Retinoic acid gamma receptor agonist | 0.051 0.003 CID_54520268 | CID_54520268 | |
| 0.046 | 0.004 | 0.046 | Nicotinic acid receptor 2 antagonist | 0.038 0.005 CID_54520268 | ||
| 0.093 | 0.052 | 0.114 | NADH dehydrogenase inhibitor | 0.114 0.032 CID_54520268 | CID_54520268 | |
| 0.162 | 0.122 | 0.218 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.218 0.059 CID_54520268 | CID_54520268 | |
| 0.044 | 0.004 | 0.046 | Retinoic acid beta receptor agonist | 0.046 0.004 CID_54520268 | CID_54520268 | |
| 0.085 | 0.045 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.021 CID_54520268 | CID_54520268 | |
| 0.059 | 0.02 | 0.059 | Aldosterone antagonist | |||
| 0.067 | 0.028 | 0.082 | Acyl-CoA dehydrogenase inhibitor | 0.082 0.021 CID_54520268 | CID_54520268 | |
| 0.045 | 0.006 | 0.047 | Retinoic acid receptor agonist | 0.047 0.005 CID_54520268 | CID_54520268 | |
| 0.096 | 0.057 | 0.096 | Alpha 2d adrenoreceptor antagonist | |||
| 0.093 | 0.055 | 0.158 | Triose-phosphate isomerase inhibitor | 0.158 0.018 CID_54520268 | CID_54520268 | |
| 0.106 | 0.069 | 0.106 | 5 Hydroxytryptamine 3A agonist | |||
| 0.101 | 0.065 | 0.101 | Alpha 2c adrenoreceptor antagonist | 0.101 0.065 CID_54520268 | ||
| 0.053 | 0.017 | 0.053 | Thymidine kinase inhibitor | 0.052 0.018 CID_54520268 | ||
| 0.136 | 0.1 | 0.136 | Growth hormone agonist | 0.13 0.107 CID_54520268 | ||
| 0.209 | 0.174 | 0.249 | Vasodilator, coronary | 0.249 0.135 CID_54520268 | CID_54520268 | |
| 0.042 | 0.007 | 0.042 | Protein kinase C beta I inhibitor | 0.04 0.009 CID_54520268 | ||
| 0.094 | 0.059 | 0.11 | ABCA1 expression enhancer | 0.11 0.039 CID_54520268 | CID_54520268 | |
| 0.061 | 0.026 | 0.061 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.155 | 0.121 | 0.155 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.049 | 0.015 | 0.051 | Kainate receptor agonist | 0.051 0.013 CID_54520268 | CID_54520268 | |
| 0.08 | 0.046 | 0.08 | Acetylcholine M4 receptor antagonist | |||
| 0.069 | 0.035 | 0.096 | Carbamoyl phosphate synthetase inhibitor | 0.096 0.022 CID_54520268 | CID_54520268 | |
| 0.057 | 0.024 | 0.057 | HCV NS3/NS4A protease inhibitor | 0.049 0.035 CID_54520268 | ||
| 0.069 | 0.037 | 0.069 | NMDA receptor agonist | 0.059 0.049 CID_54520268 | ||
| 0.084 | 0.054 | 0.084 | Estrogen-related receptor beta agonist | 0.082 0.062 CID_54520268 | ||
| 0.081 | 0.052 | 0.081 | Glutamate receptor agonist | |||
| 0.073 | 0.046 | 0.086 | Phosphofructokinase-1 inhibitor | 0.086 0.038 CID_54520268 | CID_54520268 | |
| 0.093 | 0.066 | 0.109 | Phosphodiesterase 6D inhibitor | 0.109 0.038 CID_54520268 | CID_54520268 | |
| 0.095 | 0.069 | 0.1 | Aminopeptidase B inhibitor | 0.1 0.065 CID_54520268 | CID_54520268 | |
| 0.05 | 0.025 | 0.05 | Phosphodiesterase 3B inhibitor | 0.041 0.034 CID_54520268 | ||
| 0.073 | 0.047 | 0.074 | Phospholipase D inhibitor | 0.074 0.045 CID_54520268 | CID_54520268 | |
| 0.061 | 0.036 | 0.075 | Argininosuccinate synthase inhibitor | 0.075 0.027 CID_54520268 | CID_54520268 | |
| 0.058 | 0.033 | 0.058 | Protein kinase C epsilon inhibitor | 0.058 0.033 CID_54520268 | ||
| 0.1 | 0.075 | 0.1 | DOPA decarboxylase inhibitor | 0.093 0.092 CID_54520268 | ||
| 0.109 | 0.085 | 0.125 | Cholinergic antagonist | 0.125 0.069 CID_54520268 | CID_54520268 | |
| 0.045 | 0.02 | 0.045 | Progesterone antagonist | 0.03 0.029 CID_54520268 | ||
| 0.048 | 0.025 | 0.048 | Oxytocin agonist | |||
| 0.031 | 0.009 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.015 CID_54520268 | ||
| 0.082 | 0.06 | 0.082 | GABA A receptor agonist | |||
| 0.036 | 0.014 | 0.036 | Uridine phosphorylase inhibitor | 0.034 0.015 CID_54520268 | ||
| 0.089 | 0.068 | 0.089 | Prolactin inhibitor | |||
| 0.072 | 0.051 | 0.081 | Glycine receptor agonist | 0.081 0.037 CID_54520268 | CID_54520268 | |
| 0.026 | 0.006 | 0.026 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.021 0.013 CID_54520268 | ||
| 0.034 | 0.014 | 0.034 | Calcitonin gene-related peptide antagonist | |||
| 0.077 | 0.057 | 0.087 | Interferon agonist | 0.087 0.042 CID_54520268 | CID_54520268 | |
| 0.057 | 0.038 | 0.095 | Alcohol oxidase inhibitor | 0.095 0.019 CID_54520268 | CID_54520268 | |
| 0.102 | 0.083 | 0.154 | Adenylate cyclase inhibitor | 0.154 0.043 CID_54520268 | CID_54520268 | |
| 0.038 | 0.02 | 0.047 | Tryptophan 5 hydroxylase inhibitor | 0.047 0.007 CID_54520268 | CID_54520268 | |
| 0.058 | 0.041 | 0.058 | CDK4/cyclin D1 inhibitor | |||
| 0.024 | 0.009 | 0.024 | Guanylate cyclase 1 stimulant | 0.02 0.013 CID_54520268 | ||
| 0.054 | 0.041 | 0.054 | Cyclin B2 inhibitor | |||
| 0.1 | 0.087 | 0.104 | Proteasome inhibitor | 0.104 0.082 CID_54520268 | CID_54520268 | |
| 0.065 | 0.052 | 0.077 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_54520268 | CID_54520268 | |
| 0.072 | 0.06 | 0.072 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.072 | 0.06 | 0.107 | Keratolytic | 0.107 0.027 CID_54520268 | CID_54520268 | |
| 0.068 | 0.056 | 0.075 | Aminopeptidase I inhibitor | 0.075 0.047 CID_54520268 | CID_54520268 | |
| 0.058 | 0.047 | 0.058 | Cyclin B1 inhibitor | |||
| 0.101 | 0.091 | 0.116 | Acetylcholine antagonist | 0.116 0.074 CID_54520268 | CID_54520268 | |
| 0.121 | 0.112 | 0.121 | CC chemokine 6 receptor antagonist | |||
| 0.058 | 0.049 | 0.067 | NMDA 2C receptor antagonist | 0.067 0.036 CID_54520268 | CID_54520268 | |
| 0.02 | 0.012 | 0.02 | Progesterone receptor B antagonist | |||
| 0.037 | 0.029 | 0.037 | Cyclin D3 inhibitor | |||
| 0.1 | 0.092 | 0.1 | Interleukin 2 antagonist | |||
| 0.068 | 0.06 | 0.086 | Glutamate dehydrogenase inhibitor | 0.086 0.039 CID_54520268 | CID_54520268 | |
| 0.07 | 0.063 | 0.07 | Vanilloid 4 agonist | |||
| 0.038 | 0.031 | 0.038 | AMPA 4 receptor antagonist | |||
| 0.05 | 0.043 | 0.07 | Alpha-mannosidase inhibitor | 0.07 0.017 CID_54520268 | CID_54520268 | |
| 0.036 | 0.03 | 0.036 | Glutamate (mGluR group II) antagonist | |||
| 0.059 | 0.054 | 0.059 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.029 | 0.024 | 0.041 | Cyclophilin A inhibitor | 0.041 0.011 CID_54520268 | CID_54520268 | |
| 0.073 | 0.069 | 0.073 | MAP kinase kinase 7 inhibitor | |||
| 0.037 | 0.032 | 0.044 | Retinoic acid alpha receptor agonist | 0.044 0.02 CID_54520268 | CID_54520268 | |
| 0.082 | 0.078 | 0.087 | Polo-like kinase-1 inhibitor | 0.087 0.067 CID_54520268 | CID_54520268 | |
| 0.017 | 0.013 | 0.02 | Telomerase stimulant | 0.02 0.008 CID_54520268 | CID_54520268 | |
| 0.097 | 0.094 | 0.097 | TRPA1 agonist | |||
| 0.024 | 0.022 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CID_54520268 | CID_54520268 | |
| 0.027 | 0.025 | 0.027 | Acetylcholine M4 receptor agonist | |||
| 0.027 | 0.025 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.032 | 0.03 | 0.032 | Nicotinic acid receptor agonist | |||
| 0.063 | 0.062 | 0.068 | Protein kinase C beta inhibitor | 0.068 0.051 CID_54520268 | CID_54520268 | |
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.071 | 0.07 | 0.071 | Acetylcholine M3 receptor agonist | |||
| 0.116 | 0.116 | 0.156 | Thrombolytic | 0.156 0.077 CID_54520268 | CID_54520268 | |
| 0.029 | 0.03 | 0.043 | Retinoid X receptor agonist | 0.043 0.021 CID_54520268 | CID_54520268 | |
| 0.031 | 0.033 | 0.051 | 5-Alpha-reductase inhibitor | 0.051 0.018 CID_54520268 | CID_54520268 | |
| 0.022 | 0.025 | 0.03 | Lysophosphatidic acid receptor 1 agonist | 0.03 0.011 CID_54520268 | CID_54520268 | |
| 0.106 | 0.11 | 0.204 | Protein kinase stimulant | 0.204 0.04 CID_54520268 | CID_54520268 | |
| 0.042 | 0.046 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.026 CID_54520268 | CID_54520268 | |
| 0.052 | 0.056 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 CID_54520268 | CID_54520268 | |
| 0.016 | 0.021 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.016 CID_54520268 | CID_54520268 | |
| 0.121 | 0.126 | 0.134 | Pregnane X receptor agonist | 0.134 0.088 CID_54520268 | CID_54520268 | |
| 0.056 | 0.062 | 0.103 | Phosphodiesterase 4B inhibitor | 0.103 0.024 CID_54520268 | CID_54520268 | |
| 0.048 | 0.053 | 0.062 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.062 0.033 CID_54520268 | CID_54520268 | |
| 0.093 | 0.099 | 0.124 | Acetylcholine muscarinic antagonist | 0.124 0.063 CID_54520268 | CID_54520268 | |
| 0.083 | 0.091 | 0.091 | Bile acid receptor antagonist | 0.091 0.07 CID_54520268 | CID_54520268 | |
| 0.06 | 0.068 | 0.108 | Cathepsin G inhibitor | 0.108 0.03 CID_54520268 | CID_54520268 | |
| 0.029 | 0.039 | 0.032 | Tubulin agonist | 0.032 0.028 CID_54520268 | CID_54520268 | |
| 0.009 | 0.019 | 0.014 | Lysophosphatidic acid receptor 3 agonist | 0.014 0.009 CID_54520268 | CID_54520268 | |
| 0.097 | 0.107 | 0.145 | Cyclooxygenase 3 inhibitor | 0.145 0.052 CID_54520268 | CID_54520268 | |
| 0.106 | 0.117 | 0.29 | Peroxidase inhibitor | 0.29 0.039 CID_54520268 | CID_54520268 | |
| 0.024 | 0.035 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_54520268 | CID_54520268 | |
| 0.09 | 0.102 | 0.137 | Cholesterol synthesis inhibitor | 0.137 0.052 CID_54520268 | CID_54520268 | |
| 0.078 | 0.09 | 0.09 | Creatine kinase inhibitor | 0.09 0.071 CID_54520268 | CID_54520268 | |
| 0.025 | 0.038 | 0.034 | Fumarate hydratase inhibitor | 0.034 0.024 CID_54520268 | CID_54520268 | |
| 0.047 | 0.06 | 0.065 | Acetylcholine M3 receptor antagonist | 0.065 0.036 CID_54520268 | CID_54520268 | |
| 0.11 | 0.125 | 0.138 | Acetylcholine M1 receptor antagonist | 0.138 0.087 CID_54520268 | CID_54520268 | |
| 0.013 | 0.029 | 0.021 | 5-Alpha-reductase 2 inhibitor | 0.021 0.012 CID_54520268 | CID_54520268 | |
| 0.034 | 0.05 | 0.038 | Sphingosine kinase 1 inhibitor | 0.038 0.037 CID_54520268 | CID_54520268 | |
| 0.039 | 0.057 | 0.057 | Lysophosphatidic acid 3 receptor antagonist | 0.057 0.026 CID_54520268 | CID_54520268 | |
| 0.034 | 0.053 | 0.058 | Mannosidase inhibitor | 0.058 0.018 CID_54520268 | CID_54520268 | |
| 0.007 | 0.026 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 CID_54520268 | CID_54520268 | |
| 0.111 | 0.133 | 0.172 | MAP3K9 inhibitor | 0.172 0.033 CID_54520268 | CID_54520268 | |
| 0.014 | 0.036 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.017 CID_54520268 | CID_54520268 | |
| 0.016 | 0.038 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.015 CID_54520268 | CID_54520268 | |
| 0.06 | 0.086 | 0.114 | Phosphodiesterase IV inhibitor | 0.114 0.036 CID_54520268 | CID_54520268 | |
| 0.045 | 0.071 | 0.059 | Acetylcholine M5 receptor antagonist | 0.059 0.043 CID_54520268 | CID_54520268 | |
| 0.083 | 0.113 | 0.112 | Protein kinase C gamma inhibitor | 0.112 0.059 CID_54520268 | CID_54520268 | |
| 0.02 | 0.052 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 CID_54520268 | CID_54520268 | |
| 0.052 | 0.085 | 0.09 | Glutamate decarboxylase inhibitor | 0.09 0.036 CID_54520268 | CID_54520268 | |
| 0.046 | 0.084 | 0.103 | Phenylalanine 4-hydroxylase inhibitor | 0.103 0.024 CID_54520268 | CID_54520268 | |
| 0.077 | 0.122 | 0.11 | Mucolytic | 0.11 0.064 CID_54520268 | CID_54520268 | |
| 0.072 | 0.125 | 0.099 | Anesthetic local | 0.099 0.084 CID_54520268 | CID_54520268 | |
| 0.168 | 0.224 | 0.259 | Antithrombotic | 0.259 0.119 CID_54520268 | CID_54520268 | |
| 0.068 | 0.128 | 0.089 | Alpha 2b adrenoreceptor antagonist | 0.089 0.087 CID_54520268 | CID_54520268 | |
| 0.071 | 0.132 | 0.096 | Glutamate release inhibitor | 0.096 0.049 CID_54520268 | CID_54520268 | |
| 0.066 | 0.128 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.119 0.032 CID_54520268 | CID_54520268 | |
| 0.04 | 0.103 | 0.087 | Catalase inhibitor | 0.087 0.044 CID_54520268 | CID_54520268 | |
| 0.067 | 0.131 | 0.079 | Hematopoietic | 0.079 0.076 CID_54520268 | CID_54520268 | |
| 0.114 | 0.183 | 0.175 | Insulin sensitizer | 0.175 0.101 CID_54520268 | CID_54520268 | |
| 0.182 | 0.253 | 0.436 | Antibacterial | 0.436 0.062 CID_54520268 | CID_54520268 | |
| 0.069 | 0.144 | 0.121 | Alkylator | 0.121 0.067 CID_54520268 | CID_54520268 | |
| 0.033 | 0.117 | 0.068 | Antineoplastic antibiotic | 0.068 0.067 CID_54520268 | CID_54520268 | |
| 0.057 | 0.143 | 0.089 | Expectorant | 0.089 0.083 CID_54520268 | CID_54520268 | |
| 0.044 | 0.138 | 0.153 | Somatostatin 1 agonist | 0.153 0.013 CID_54520268 | CID_54520268 | |
| 0.084 | 0.18 | 0.208 | Cell wall synthesis inhibitor | 0.208 0.027 CID_54520268 | CID_54520268 | |
| 0.035 | 0.138 | 0.069 | Beta adrenoreceptor antagonist | 0.069 0.04 CID_54520268 | CID_54520268 | |
| 0.045 | 0.151 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.043 CID_54520268 | CID_54520268 | |
| 0.012 | 0.125 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CID_54520268 | CID_54520268 | |
| 0.041 | 0.167 | 0.11 | Adrenaline agonist | 0.11 0.031 CID_54520268 | CID_54520268 | |
| 0.087 | 0.214 | 0.222 | Nitric oxide antagonist | 0.222 0.06 CID_54520268 | CID_54520268 | |
| 0.055 | 0.192 | 0.105 | Amylase inhibitor | 0.105 0.092 CID_54520268 | CID_54520268 | |
| 0.021 | 0.162 | 0.049 | Beta 1 adrenoreceptor antagonist | 0.049 0.048 CID_54520268 | CID_54520268 | |
| 0.015 | 0.172 | 0.042 | Growth hormone release inhibitor | 0.042 0.029 CID_54520268 | CID_54520268 | |
| 0.054 | 0.221 | 0.409 | Phosphodiesterase inhibitor | 0.409 0.006 CID_54520268 | CID_54520268 | |
| 0.12 | 0.306 | 0.265 | Peptidyltransferase inhibitor | 0.265 0.041 CID_54520268 | CID_54520268 | |
| 0.111 | 0.316 | 0.424 | Immunosuppressant | 0.424 0.055 CID_54520268 | CID_54520268 | |
| 0.056 | 0.265 | 0.158 | EphB2 antagonist | 0.158 0.122 CID_54520268 | CID_54520268 | |
| 0.027 | 0.239 | 0.089 | Adrenaline antagonist | 0.089 0.061 CID_54520268 | CID_54520268 | |
| 0.028 | 0.24 | 0.09 | Antiadrenergic | 0.09 0.062 CID_54520268 | CID_54520268 | |
| 0.01 | 0.227 | 0.057 | Somatostatin 1 antagonist | 0.057 0.017 CID_54520268 | CID_54520268 | |
| 0.004 | 0.291 | 0.038 | Somatostatin 5 antagonist | 0.038 0.019 CID_54520268 | CID_54520268 | |
| 0.007 | 0.309 | 0.021 | Somatostatin 4 antagonist | 0.021 0.02 CID_54520268 | CID_54520268 | |
| 0.034 | 0.4 | 0.126 | Electron transport complex I inhibitor | 0.126 0.04 CID_54520268 | CID_54520268 | |
| 0.105 | 0.515 | 0.728 | Antiinflammatory | 0.728 0.026 CID_54520268 | CID_54520268 | |
| 0.053 | 0.627 | 0.316 | Cyclophilin D inhibitor | 0.316 0.149 CID_54520268 | CID_54520268 | |
| 0.007 | 0.591 | 0.059 | Neuraminidase (influenza) inhibitor | 0.059 0.057 CID_54520268 | CID_54520268 | |
| 0.015 | 0.685 | 0.2 | Interleukin antagonist | 0.2 0.084 CID_54520268 | CID_54520268 | |
| 0.006 | 0.73 | 0.116 | Bronchodilator | 0.116 0.047 CID_54520268 | CID_54520268 | |
| 0.015 | 0.765 | 0.13 | Nav1.4 sodium channel blocker | 0.13 0.044 CID_54520268 | CID_54520268 | |
| 0.006 | 0.892 | 0.776 | Toll-Like receptor 7 agonist | 0.776 0.005 CID_54520268 | CID_54520268 | |
| 0.006 | 0.895 | 0.771 | Toll-Like receptor agonist | 0.771 0.005 CID_54520268 | CID_54520268 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |